ANALYSIS: Australian device approvals could slide further with scrutiny hurdles
This article was originally published in SRA
Executive Summary
The number of new medtech products on the Australian market has slowly declined over the six months to March 2013 and looks set to fall further if, as expected, tougher approval requirements are introduced for higher risk products.